Animesh Agarwal, MD
Orthopaedic Surgery · San Antonio, TXNPI 1699882761
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Smith+Nephew at 34.9% of the total. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 574 payments — averaging $711.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$142K
- KCI USA, Inc.$117K
- Sanara Medtech Inc.$38K
- Solventum Corporation$35K
- Bonebridge Inc.$21K
- Bone Support Inc.$20K
- plus $35K from 29 others
Across 9 payments — averaging $3480.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$21K
- BONE Support AB$11K
What the payments were for
- Consulting fees$86,21721%
- Speaking & faculty fees$223,24255%
- Travel & lodging$64,20816%
- Food & beverage$27,0887%
- Education$7,5402%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 162 | $142,499 |
| KCI USA, Inc. | 100 | $117,356 |
| Sanara Medtech Inc. | 74 | $37,530 |
| Solventum Corporation | 24 | $35,105 |
| Bonebridge Inc. | 3 | $20,827 |
| Bone Support Inc. | 19 | $20,463 |
| Bioventus LLC | 70 | $14,544 |
| Synthes GmbH | 12 | $8,392 |
| Osteocentric Technologies, Inc. | 29 | $2,801 |
| Musculoskeletal Transplant Foundation Inc. | 13 | $2,419 |
| Johnson & Johnson(2 entities) | 17 | $1,754 |
| Stryker | 11 | $1,321 |
| Si-bone, Inc. | 5 | $523 |
| Acera Surgical, Inc. | 4 | $393 |
| Medela LLC | 5 | $344 |
| Kerecis Limited | 4 | $281 |
| Medline Industries LP | 3 | $257 |
| TELA Bio, Inc. | 1 | $157 |
| Onkos Surgical, Inc. | 1 | $156 |
| Integra Lifesciences Corporation | 1 | $132 |
| Medtronic | 1 | $127 |
| Organogenesis Inc. | 1 | $121 |
| Curvafix, Inc. | 1 | $119 |
| Amgen | 1 | $117 |
| DJO, LLC | 1 | $113 |
| Carbofix Orthopedics Inc | 1 | $105 |
| Zimmer Biomet | 1 | $75 |
| Convatec Inc. | 1 | $71 |
| Wound Management Technologies, Inc | 2 | $57 |
| Mimedx Group, Inc. | 1 | $34 |
| Vertex | 1 | $26 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Medinc Of Texas | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$148,348
- PREVENA$127,566
- V.A.C. VERAFLO$72,824
- EVOS MINI$39,040
- TRIGEN$35,673
- CellerateRx$31,933
- V.A.C. VERAFLO CLEANSE CHOICE$25,594
- Peri-Loc VLP$24,188
- Peri-Loc$24,188
- CANNULATED SCREWS$24,123
- META TAN$23,631
- Peri-Loc PFP$23,631
- CERAMENTBONE VOID FILLER$20,333
- TRIGEN InterTAN$20,052
- TRIGEN Femoral (FAN/TAN/Meta Nail)$14,551
- Conquest FN$13,750
- 3M Skin and Nasal Antiseptic$13,690
- Taylor Spatial Frame$13,686
- Exogen Ultrasound Bone Healing System$13,172
- 3M DuraPrep Surgical$13,165
How this compares
$408,295 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 20 | $243 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Christopher ChaputSan Antonio$959K
- Frank ButtacavoliSan Antonio$866K
- Robert HartzlerSan Antonio$654K
- Bernard MorreySan Antonio$639K
- Ralph GarzaSan Antonio$390K
- Anil DuttaSan Antonio$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.